Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenSignal Bio Pharma Private Limited (GSBPL) is an Indian pharmaceutical and vaccine manufacturing company founded in 2005 and based in Chennai, Tamil Nadu. The company is one of only a few manufacturers globally pre-qualified by the World Health Organization (WHO) to supply the Bacillus Calmette-Guérin (BCG) vaccine to UNICEF. GSBPL's commercial portfolio includes BCG Vaccine (Freeze Dried) IP/BP/EP for tuberculosis immunization and BCG ONCO (Urovac) for the intravesical immunotherapy of non-muscle-invasive bladder cancer. The company operates a state-of-the-art manufacturing facility in Gummidipoondi, Tamil Nadu, with a capacity to produce hundreds of millions of doses annually. Additionally, GSBPL is developing a pipeline of other essential vaccines, including candidates for tetanus, rabies, and MMR (Measles, Mumps, and Rubella).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenSignal BioPharma.